Adult Stem Cells Market
Adult Stem Cells Market - Global Industry Assessment & Forecast
Segments Covered
- By Type Epithelial Stem Cells, Hematopoietic Stem Cells
- By Application Therapeutics,, Disease Modeling,, Drug Development & Discovery,, Toxicology Studies,, Biobanking,, Tissue Engineering,, Others
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2024 |
Forecast Years: | 2025 - 2034 |
Historical Years: | 2019 - 2023 |
Revenue 2024: | USD 9.24 Billion |
Revenue 2034: | USD 23.96 Billion |
Revenue CAGR (2025 - 2034): | 10.0% |
Fastest Growing Region (2025 - 2034) | XX |
Largest Region (2024): | XX |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
-
Executive Dashboard
- Strategic Imperatives
-
Premium Insights
- Top 3 Trends to Watch
- Demand and Supply Trends
- Top 3 Strategies Followed by Major Players
- Top 3 Predictions by Vantage Market Research
- Top Investment Pockets
- Insights from Primary Respondents
-
Global Adult Stem Cells Market - Segment Analysis
- Overview
- Global Adult Stem Cells Market, 2016 - 2028 (USD Million)
-
Global Adult Stem Cells Market - by Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
-
Global Adult Stem Cells Market - by Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
-
Global Adult Stem Cells Market - by region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Market comparative analysis
-
North America Adult Stem Cells Market - Segment Analysis
- Overview
- North America Adult Stem Cells Market, 2016 - 2028 (USD Million)
-
North America Adult Stem Cells Market, by Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
-
North America Adult Stem Cells Market, by Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
-
North America Adult Stem Cells Market, by Country
- U.S.
- U.S. Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- U.S. Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- U.S. Adult Stem Cells Market, By Type
- Canada
- Canada Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- Canada Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- Canada Adult Stem Cells Market, By Type
- Mexico
- Mexico Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- Mexico Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- Mexico Adult Stem Cells Market, By Type
- U.S.
-
Europe Adult Stem Cells Market - Segment Analysis
- Overview
- Europe Adult Stem Cells Market, 2016 - 2028 (USD Million)
-
Europe Adult Stem Cells Market, by Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
-
Europe Adult Stem Cells Market, by Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
-
Europe Adult Stem Cells Market, by Country
- Germany
- Germany Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- Germany Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- Germany Adult Stem Cells Market, By Type
- UK
- UK Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- UK Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- UK Market, By Type
- France
- France Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- France Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- France Adult Stem Cells Market, By Type
- Spain
- Spain Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- Spain Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- Spain Adult Stem Cells Market, By Type
- Italy
- Italy Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- Italy Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- Italy Adult Stem Cells Market, By Type
- BENELUX
- BENELUX Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- BENELUX Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- BENELUX Adult Stem Cells Market, By Type
- Rest of Europe
- Rest Of Europe Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- Rest Of Europe Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- Rest Of Europe Adult Stem Cells Market, By Type
- Germany
-
Asia Pacific Adult Stem Cells Market - Segment Analysis
- Overview
- Asia Pacific Adult Stem Cells Market, 2016 - 2028 (USD Million)
-
Asia Pacific Adult Stem Cells Market, by Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
-
Asia Pacific Adult Stem Cells Market, by Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
-
Asia Pacific Adult Stem Cells Market, by Country
- China
- China Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- China Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- China Adult Stem Cells Market, By Type
- Japan
- Japan Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- Japan Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- Japan Adult Stem Cells Market, By Type
- India
- India Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- India Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- India Adult Stem Cells Market, By Type
- South Korea
- South Korea Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- South Korea Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- South Korea Adult Stem Cells Market, By Type
- South East Asia
- South East Asia Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- South East Asia Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- South East Asia Adult Stem Cells Market, By Type
- Rest of Asia Pacific
- Rest of Asia Pacific Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- Rest of Asia Pacific Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- Rest of Asia Pacific Adult Stem Cells Market, By Type
- China
-
Latin America Adult Stem Cells Market - Segment Analysis
- Overview
- Latin America Adult Stem Cells Market, 2016 - 2028 (USD Million)
-
Latin America Adult Stem Cells Market, by Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
-
Latin America Adult Stem Cells Market, by Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
-
Latin America Adult Stem Cells Market, by Country
- Brazil
- Brazil Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- Brazil Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- Brazil Adult Stem Cells Market, By Type
- Argentina
- Argentina Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- Argentina Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- Argentina Adult Stem Cells Market, By Type
- Rest of Latin America
- Rest of Latin America Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- Rest of Latin America Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- Rest of Latin America Adult Stem Cells Market, By Type
- Brazil
-
Middle East & Africa Adult Stem Cells Market - Segment Analysis
- Overview
- Middle East & Africa Adult Stem Cells Market, 2016 - 2028 (USD Million)
-
Middle East & Africa Adult Stem Cells Market, by Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
-
Middle East & Africa Adult Stem Cells Market, by Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
-
Middle East & Africa Adult Stem Cells Market, by Country
- GCC Countries
- GCC Countries Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- GCC Countries Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- GCC Countries Adult Stem Cells Market, By Type
- South Africa
- South Africa Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- South Africa Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- South Africa Adult Stem Cells Market, By Type
- Rest of Middle East & Africa
- Rest of Middle East & Africa Adult Stem Cells Market, By Type
- By Epithelial Stem Cells
- By Hematopoietic Stem Cells
- Rest of Middle East & Africa Adult Stem Cells Market, By Application
- By Therapeutics,
- By Disease Modeling,
- By Drug Development & Discovery,
- By Toxicology Studies,
- By Biobanking,
- By Tissue Engineering,
- By Others
- Rest of Middle East & Africa Adult Stem Cells Market, By Type
- GCC Countries
-
Key Market Dynamics
- Introduction
- Market Drivers
- Market Restraints
- Market Opportunities
- Porter's Five Forces Analysis
- PEST Analysis
- Regulatory Landscape
- Technology Landscape
- Regional Market Trends
-
COVID 19 Impact Analysis
- Key strategies undertaken by companies to tackle COVID-19
- Short term dynamics
- Long term dynamics
-
Marketing Stratagy Analysis
- Marketing Channel
- Direct Marketing
- Indirect Marketing
- Marketing Channel Development Trends
-
Competative Landscape
- Competition Matrix - 2021
- Company Market Share Analysis - 2021
- Key Company Activities, 2018 - 2021
- Strategic Developments - Heat Map Analysis
- Company Offering Evaluation
- Company Regional Presence Evaluation
-
Company Profiles
- Intellicell Biosciences Inc.
- Globalstem
- Neurogeneration
- Capricor Inc.
- Caladrius Biosciences Inc.
- Mesoblast Ltd.
- Celyad
- Juventas Therapeutics Inc.
- Cytori Therapeutics Inc.
- Cellular Dynamics International
- Epistem Ltd.
- Brainstorm Cell Therapeutics Inc.
- Cellerant Therapeutics Inc.
- Hybrid Organ Gmbh
- Cellerix Sa.
- Key Primary Respondents - VERBATIM
- Discussion Guide
- Customization Offered
- Annexure
- List of Figures
- List of Tables
- List of Abbreviations
FAQ
Frequently Asked Question
What is the global demand for Adult Stem Cells in terms of revenue?
-
The global Adult Stem Cells valued at USD 9.24 Billion in 2024 and is expected to reach USD 23.96 Billion in 2034 growing at a CAGR of 10.0%.
Which are the prominent players in the market?
-
The prominent players in the market are Intellicell Biosciences Inc., Globalstem, Neurogeneration, Capricor Inc., Caladrius Biosciences Inc., Mesoblast Ltd., Celyad, Juventas Therapeutics Inc., Cytori Therapeutics Inc., Cellular Dynamics International, Epistem Ltd., Brainstorm Cell Therapeutics Inc., Cellerant Therapeutics Inc., Hybrid Organ Gmbh, Cellerix Sa..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 10.0% between 2025 and 2034.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Adult Stem Cells include
Which region accounted for the largest share in the market?
-
XX was the leading regional segment of the Adult Stem Cells in 2024.